The impact of apolipoprotein (apo) E genotype variation on means, variances and correlations between plasma lipid traits was studied in male and female octogenarians. Females had significantly higher mean levels of all 10 of the measured plasma lipid traits than males. The subset of concomitants (Le., age, height, weight, body mass index, glucose and uric acid) that made a statistically significant contribution to interindividual variability was different in males and females for every trait considered. Gender-specific associations between variation in apo E genotype and variation in particular measures of lipid metabolism, adjusted for concomitant variation, were observed in females there were no statistically significant associations while in males the means of the three common apo E genotypes were significantly different for adjusted measures of total cholesterol, low density lipoprotein cholesterol and low density lipoprotein-apo B. The common apo E genotypes were heterogeneous with respect to intragenotypic variance for adjusted logtransformed triglyceride levels in females only. Finally, the three common apo E genotypes were heterogeneous with respect to the correlation between traits, adjusted for concomitant variation, and gender influenced the manner in which the genotypes differed for specific correlations. This study documents that variation in the apo E gene has a significant impact on means, variances Received for publication September 9, 1994; revision received April 7, 1995. Address reprint requests to Martha B. Haviland, Ph.D., Department of Human Genetics, M4708 Medical Science Bldg. 11, University of Michigan Medical School, Ann Arbor, MI 48109-0618. and correlations of plasma lipid traits in octogenarians, but the effects are context-, that is, gender-and age-, dependent. KEY WORDS: apolipoprotein E, means, variances, correlations, octogenarians, aging, plasma lipid traits, gender INTRODUCTION The common polymorphic alleles of the gene coding for apolipoprotein (apo) E, €2, €3 and €4, have been shown to be associated with variation in plasma lipoprotein levels in samples of both healthy [Sing and Davignon, 1985; Boerwinkle et al., 1987; Kaprio et al., 1991; Reilly et al., 1991; Xhignesse et al., 1991; Davignon, 19931 and diseased individuals (for a review see Davignon et al., 1988b; Davignon, 1993) . The €4 allele is associated with increased levels of low density lipoprotein cholesterol (LDL-C) and apo B, and thus is hypothesized t o be associated with increased risk of coronary artery disease (CAD). This hypothesis is supported by cross-sectional studies demonstrating an association between the €4 allele and presence of CAD [Cumming and Robertson, 1984; Kuusi et al., 1989; Pedro-Botet et al., 1992; Eichner et al., 19931 and by a prospective study in which the €4 allele was predictive of CAD mortality [StengBrd et al., 19951. There is evidence that the presence of the €4 allele may be a risk factor for CAD even in the absence of elevated plasma LDL-C [Hixson et al., 19911. The €2 allele is associated with decreased levels of LDL-C, a potentially antiatherogenic effect. It may also be associated with increased concentrations of triglyceride-rich lipoproteins and thus could, in some circumstances, favor the development of atherosclerosis. These findings have led to the hypothesis that variation in the apo E gene may play an important role in determining interindividual variation in risk of atherosclerosis in general and of 0 1995 Wiley-Liss, Inc.
INTRODUCTION
The common polymorphic alleles of the gene coding for apolipoprotein (apo) E, €2, €3 and €4, have been shown to be associated with variation in plasma lipoprotein levels in samples of both healthy [Sing and Davignon, 1985; Boerwinkle et al., 1987; Kaprio et al., 1991; Reilly et al., 1991; Xhignesse et al., 1991; Davignon, 19931 and diseased individuals (for a review see Davignon et al., 1988b; Davignon, 1993) . The €4 allele is associated with increased levels of low density lipoprotein cholesterol (LDL-C) and apo B, and thus is hypothesized t o be associated with increased risk of coronary artery disease (CAD). This hypothesis is supported by cross-sectional studies demonstrating an association between the €4 allele and presence of CAD [Cumming and Robertson, 1984; Kuusi et al., 1989; Pedro-Botet et al., 1992; Eichner et al., 19931 and by a prospective study in which the €4 allele was predictive of CAD mortality [StengBrd et al., 19951 . There is evidence that the presence of the €4 allele may be a risk factor for CAD even in the absence of elevated plasma LDL-C [Hixson et al., 19911 . The €2 allele is associated with decreased levels of LDL-C, a potentially antiatherogenic effect. It may also be associated with increased concentrations of triglyceride-rich lipoproteins and thus could, in some circumstances, favor the development of atherosclerosis. These findings have led to the hypothesis that variation in the apo E gene may play an important role in determining interindividual variation in risk of atherosclerosis in general and of CAD in particular [Davignon et al., 198813; Davignon, 1991, 19931. This study is one in a series of studies examining the effects of apo E genotype variation on the phenotypic distributions of measures of lipid metabolism in octogenarians. A previous study, using the same sample analyzed here, demonstrated that the relative frequency of the €4 allele was decreased in octogenarians as compared to normal subjects of a younger age group [Davignon et al., 1988a, 19891 . Based on the fact that cardiovascular diseases and, specifically CAD, constitute, in a progressive fashion, the principal cause of mortality with aging, this finding is consistent with the hypothesis that genetic variation in apo E influences variation in risk of CAD. In these previous studies, gender differences in the apo E allele frequencies and in the plasma lipid levels and clinical phenotypes of the octogenarians were observed [Davignon et al., 1988a, 19891 . The decrease in the €4 allele frequency was statistically significant in females only and a n enrichment in the €2 allele was present in males but was not statistically significant. Also, female octogenarians had a higher frequency of hyperlipidemia, hypertension, and CAD and lower frequency of smoking and exercise than male octogenarians.
To further study the impact of variation in the apo E gene on the phenotypic distributions of measures of lipid metabolism in octogenarians, the effects of apo E genotype variation on means, variances and correlations between plasma lipid, lipoprotein and apolipoprotein traits were estimated, after adjustment for concomitants, separately in males and females. This study suggests that variation in the apo E gene is involved in the modulation of lipid metabolism differently in male and female octogenarians. Our findings are discussed in the context of previously published work in samples of younger individuals to draw conclusions about the effects of aging on the impact of variation in the apo E gene on the phenotypic distributions of measures of lipid metabolism.
MATERIALS AND METHODS
Sample Octogenarian subjects were recruited from 6 homes for the aged and one Veterans Hospital. As described previously [Davignon et al., 1988a, 19891 , the subjects were selected to be ambulatory and autonomous, at least 80 years old, capable of answering a questionnaire and willing to submit to a short physical examination and the drawing of blood. Exclusion criteria included subjects with chronic debilitating disease (e.g., cancer, Parkinson's disease, etc.), mental illness, alcoholism, untreated hypothyroidism, or within the previous three months, major surgery, weight change (?lo%) or a myocardial infarction. The sample analyzed here consisted of 236 unrelated octogenarians (118 females and 118 males).
Laboratory Methods
Laboratory methods are described in detail elsewhere [Davignon et al., 1988a, 19891 . Briefly, blood samples were obtained after a 12 hour fast and separated for automatic enzymatic determination of plasma total cholesterol (TC) [Allain et al., 19741, triglycerides (TG) [Sampson et al., 19751, glucose [Richterich and Dauwalder, 19711 and uric acid [Kageyama, 19711. Plasma lipoproteins were separated according to the Lipid Research Clinics protocol [Lipid Research Clinics Program, 19741 . Plasma apo B, LDL-apo B (LDL-B) and very low density lipoprotein-apo B (VLDL-B) concentrations were determined using the method of Reardon et al. [1981] with the modification of Rosseneu et al. [1981] . The subfractions of plasma high density lipoprotein cholesterol, HDLB-C and HDL3-C, were determined after precipitation of HDL2 [Gidez et al., 19821 . Apo E phenotyping was done on the washed VLDL fraction by unidimensional isoelectric focusing on polyacrylamide gel [Bouthillier et al., 19831 . Six apo E genotypes, €212, €312, €313, €413, €412 and €414, were inferred from the isoform phenotypes, E2l2, E3l2, E3l3, E4l3, E4l2 and E4l4, coded by the three polymorphic alleles, €2, €3 and €4.
Statistical Methods
All analyses were carried out using the SAS software package [SAS Institute Inc., 19891 . Statistical tests that gave P-values less than or equal to 0.05 were considered significant. All analyses were performed separately on males and females. Triglycerides, VLDL-C, VLDL-B and HDL3-C were not normally distributed in males and females, while LDL-C, HDL-C, HDLB-C, apo B and LDL-B were not normally distributed in males only (results not shown). Many of the statistical tests performed here are sensitive to deviations from normality, so the plasma lipid traits were analyzed both transformed with the natural logarithm and untransformed. The untransformed results are presented and those instances in which a deviation from normality affected the inferences drawn are noted.
The means, standard deviations and ranges of the concomitants (i.e., age, height, weight, body mass index (BMI), glucose and uric acid) and measures of lipid metabolism were estimated. Differences between males and females were tested using a t-test for means and a F-statistic for variances. To test whether the observed heterogeneity in the intragenotypic variances among the three common apo E genotypes was statistically significant, Bartlett's test was used [ Sokal and Rohlf, 19811. Multiple linear regression was employed to study interindividual variability associated with concomitants [Neter et al., 19851 . Model fitting was done in two ways. First, we used a stepwise procedure to evaluate which of the concomitants made a statistically significant contribution to interindividual variability in the plasma lipid traits. The inferences made are conditional on the order in which the concomitants were fit. The order selected was: age, height, weight, BMI, glucose and then uric acid. As each concomitant was added to the model, we tested the hypothesis that the concomitant explained a significant fraction of interindividual plasma lipid variability given the other concomitants already present in the model. A concomitant was retained in the model if it significantly explained interindividual variability in at least one plasma lipid trait. If a concomitant was retained in the model, the concomitant squared was added to the model and if the squared term was statistically significant in at least one trait it was retained in all models and the cubed term was tested. If the squared term was not significant for any plasma lipid trait, the cubed term was not tested, the squared term was removed from the model, and the analysis progressed to the next concomitant. The cubed and fourth-order terms were tested analogously. The second modelling strategy was to fit a most complete model to remove as much interindividual variability attributable to concomitant variability as possible. The most complete model included age, height, weight, BMI, glucose and uric acid all to the fourth order. All tests of significance about the contribution of concomitants were made using the error sum of squares associated with the most complete model. A few outliers (7 females and 8 males) with values greater than 3 standard deviations from the gender-specific mean for one or more concomitant traits were found to have a large impact on the results. All models were fit with and without these outliers in the analysis.
To estimate the association between apo E genotype variability and interindividual variability in adjusted plasma lipid levels, the apo E genotypes were added to the most complete model described above. Thus, the inferences made about the impact of the apo E genotypes on plasma lipid variability are conditional on the removal of the contribution of concomitants.
After adjusting the plasma lipid levels using the most complete model, the Pearson product moment correlations between the adjusted plasma lipid levels were estimated for each of the common apo E genotypes for each gender. The hypothesis of homogeneity of correlation among these genotypes was tested within each gen-
Impact of Apo E in Octogenarians 317
der [Sokal and Rohlf, 19811 . The Pearson product moment correlations and the tests of homogeneity of correlation of the adjusted plasma lipid traits for each of the common apo E genotypes for each gender are given in Appendices B and C. The results for all correlations, except those involving total cholesterol, total apo B and total HDL-C, are also depicted in Figures 2 and 3 . Statistical significance depends both on the size of the correlation and the sample size. For the comparison among the apo E genotypes, each with different sample sizes, the figures show the biologically significant [Hennekens and Buring, 19871 but not always statistically significant correlations. We define biologically significant correlations as those greater than 0.3 or less than -0.3. The statistical significance levels for all correlations and tests of the hypothesis of homogeneity of correlation are given in Appendices B and C and will be stated in the text. Those instances in which inferences changed when the plasma lipid traits were log,-transformed before the adjustment are noted in Appendices A-C, and the figures depict the log,-transformed results.
RESULTS
The means, standard deviations and ranges for the concomitants and measures of plasma lipid metabolism are given in Table I . Males and females were significantly different for means andlor variances for every concomitant except uric acid and diastolic blood pressure. On the average, females were younger, shorter, weighed less and had lower glucose and uric acid levels, but their blood pressure was higher than males. Females also had significantly higher average levels of all of the measures of plasma lipids than males. Finally, females had significantly greater interindividual variation in BMI, HDL3-C, LDL-B and log,-transformed VLDL-B levels and significantly less interindividual When the assumption of equal variances was violated, Satterthwaite's approximation was used. When log,-transformed, variances significantly heterogeneous (P 5 0.01).
variation in age, glucose and HDL2-C levels than males. These results show that there are significant gender differences in the distributions of both concomitants and plasma measures of lipid metabolism in octogenarians.
The results of the stepwise regression to determine which concomitants made a significant contribution to interindividual plasma lipid trait variability are given in Appendix A. Concomitants were statistically significant in the first, second and/or third order. The fourth order term was not statistically significant for any concomitant in any trait. A summary of those concomitants that made a statistically significant contribution to interindividual variation in each plasma lipid trait is given in Figure 1 . The regression results can be summarized by recognizing that interindividual variability in each plasma lipid trait was associated with variability in a different set of concomitants. Also, by comparing the upper and lower triangles in Figure 1 , differences between the genders are clearly apparent. For every plasma lipid trait studied, the set of statistically significant concomitants was different between males and females. Table I1 gives the means and standard deviations of the adjusted plasma lipid levels (adjusted using the most complete model, i.e., age, height, weight, BMI, glucose and uric acid all to the fourth order) by apo E genotype separately for males and females. In males, all six of the possible apo E genotypes were present in our sample, but in females only the three most common genotypes, €312, €313 and €413, were present. Table I11 gives the percentage of interindividual trait variability explained by concomitant variability (using the most complete model), the percentage explained by apo E genotype variability after removing the contribution of the concomitants, the percentage left unexplained and BM' I I I the total sum of squares. The percent sum of squares attributable to the concomitant variability ranged from 22% for LDL-B t o 44% for triglycerides in females and from 17% for HDL3-C to 36% for HDLB-C in males. Although the percent sum of squares attributable to variability in concomitants was similar in males and females for most traits, the absolute sum of squares attributable to variability in the concomitants, as well as the total sum of squares, was greater in females than in males for all traits except HDL-C and HDL2-C.
As was the case for the regression of plasma lipid traits on concomitants, the fraction of the total interindividual variability in this sample attributable to apo E genotype variability, after considering the concomitants, was also very different in males and females (Table 111 ). In females, apo E genotype variability did not significantly contribute to adjusted interindividual variability in any of the plasma traits considered. Not only was the percent sum of squares attributable to apo E genotype variability small in females, but also the absolute sum of squares attributable to apo E genotype variability was smaller than that in males even though the total sum of squares was greater in females for most of the traits. In all males, apo E genotype variability had a significant effect on interindividual variability in every lipid trait except HDL-C (both fractions). When the analysis was restricted to males carrying only the three most common apo E genotypes, €312, €313 and €413, concomitants explained about the same amount of plasma lipid trait variability. In this reduced data set, variability in apo E genotype had a statistically significant effect on interindividual variability in adjusted measures of LDL metabolism only.
The three common apo E genotypes explained 9.7% of the total sum of squares for adjusted total cholesterol, 11.2% for adjusted LDL-C, 9.5% for adjusted apo B, and Fig. 1 . Concomitant variables (in the first, second and/or third order) in females (upper stippled triangle) and in males (lower solid triangle) that significantly contributed to plasma lipid Variability. Concomitants that were statistically significant in all analyses, only when the outliers were removed from the analysis, or only when the dependent variable was log,-transformed, are included in the figure. Those concomitants that were significant only when the outliers were included were omitted from the figure. See Appendix A for further details. * Adjusted using the most complete model, that is, age, height, weight, BMI, glucose and uric acid all to the fourth order.
11.0% for adjusted LDL-B. The levels for these traits were lower in males with the €312 genotype than males with either the €313 or ~4 / 3 genotypes ( Table 11) . The lack of a statistically significant contribution of the apo E genotypes to interindividual variability in triglycerides, VLDL-C and VLDL-B in the subgroup was due to the removal of 2 individuals, an €212 male with very high and an €414 male with very low adjusted triglycerides, VLDL-C and VLDL-B levels (results not shown). For all traits, in both females and males, more than 50% of the interindividual variability was not explained by the predictors considered here. a Con: percent sum of squares attributable to most complete model; ApoE: percent sum of squares attributable to apo E genotypes after adjustment for concomitants; Unexp: percent sum of squares not explained by concomitants and apo E genotypes; SST total sum of squares.
Statistically significant contribution of concomitants, P-value 5 0.05, using an F-test with 24 and 91 (females), 88 (all males) or 86 (€32, $33, €43 males only) degrees of freedom.
Statistically significant contribution of apo E genotypes, P-value 5 0.05, using an F-test with 2 and 91 (females), 5 and 88 (all males) or 2 and 86 (€32, ~3 3 , -~4 3 m a l e s only) degrees of freedom.
'Inferences about the effects of the three most common apo E genotypes on trait means did not change when the dependent variable was log.-transformed before the adjustment.
The intragenotypic variances among the three most common apo E genotypes were heterogeneous (P-value 5 0.05). Intragenotypic variances not significantly heterogeneous when dependent variable log,-transformed before adjustment.
In males, the intragenotypic variances of adjusted VLDL-C, VLDL-B and HDL-C were heterogeneous among the three most common apo E genotypes, but when the plasma lipid traits were log,-transformed before the adjustment for concomitants, the variances were not significantly heterogeneous (these results are noted in Table I11 and the intragenotypic standard deviations are given in Table 11 ). In females, the intragenotypic variances for adjusted VLDL-C and triglycerides were heterogeneous among the apo E genotypes, and the intragenotypic variances of adjusted triglycerides remained significantly heterogeneous when the data were first log,-transformed. c3/3 females were the least variable, then c3/2 females and finally c4/3 females were the most variable in adjusted log,-transformed triglyceride levels.
All Pearson product moment correlations and the tests of the hypothesis of homogeneity of correlation among the common apo E genotypes are given in Appendices B and C. Those considered to be biologically significant because they exceeded 50. females were statistically significant. There were a number of other correlations in this group that were also statistically significant but were not included in Figure 2 because they did not exceed 20.30. All the correlations greater than 0.50 or less than -0.50 (medium or thick lines) were statistically significant in the ~3 / 2 females and all correlations depicted in Figure 2 except the HDL2-C:VLDL-B and LDL-C :VLDL-C correlations were statistically significant in the c4/3 females. The differences in the LDL-C:HDL3-C and LDL-B : HDL3-C correlations between the c3/3 and ~3 / 2 females were statistically significant, while the LDL-C : triglycerides, LDL-B : triglycerides and LDL-B : VLDL-C correlation differences were marginally significant (P 5 0.10). In general, the correlations involving HDL3-C were stronger (i.e., more negative) in the ~3 / 2 females than the €313 females, while correlations involving LDL (either LDL-C or LDL-B) and triglycerides, VLDL-C or VLDL-B were stronger (i.e., more positive) in ~3 / 3 females than in €31.2 females. The c3/3 and c3/4 females were similar for all correlations except the LDL-B :VLDL-C and HDL2-C : LDL-C correlations, and the tests of these differences were not statistically significant. Thus, the comparison of correlation matrices indicates that the correlations in the ~3 / 3 females were more positive than the correlations in either the €312 or €413 females and that the €413 females resembled the €313 females more than did the €312 females.
In males, all the correlations depicted in Figure 3 , except those ranging between -0.50 and +0.50 (the thin lines) in the ~3 / 2 and ~4 / 3 males, were statistically significant. As in females, the comparison of correlation matrices in males also showed that the correlations in the €313 males were, in general, more positive than the correlations in either the €312 or €413 males. In the ~3 / 3 -€312 difference map, all of the differences greater than 0.3 involved LDL-C, LDL-B, HDLB-C and HDL3-C, and all except the differences in the HDL3-C : LDL-B and HDL3-C : LDL-C correlations were statistically significant. Generally the correlations involving HDL2-C were stronger (i.e., more negative) in €312 males than €313 males. In the ~3 / 3 -~4 / 3 difference map, none of the tests of the differences depicted in Figure 3 were statistically significant. In conclusion, as in the females, the ~4 / 3 males were more similar to the ~3 / 3 males than the €312 males and the adjusted plasma lipid traits were more positively correlated in €313 males than in the others.
As mentioned earlier, the interindividual variances of many of the plasma lipid traits were heterogeneous between the genders. Thus, tests of the homogeneity of correlation between the genders would be uninformative with respect to covariation differences [Reilly et al., 19941 . Even so, there are some general trends that can be detected. As can be seen in Figure 4 , the correlations in the €313 males and females were very similar. In contrast, the males and females appeared to have heterogeneous correlations when they were compared within the ~3 / 2 or €413 genotypes. In general, the correlations were stronger in the €312 males than in the €312 females, while the correlations were stronger in the ~4 / 3 females than in the €413 males. Thus, the €413 and €312 genotypes deviated from the more common €313 genotype with regard to correlation, as discussed above, but how they deviated may be gender dependent.
DISCUSSION
Octogenarians are a particularly appropriate subset of the population for studying the effects of aging and gender on the impact of variation in the apo E gene on the genetic architecture of the phenotypic distributions of plasma measures of lipid metabolism. This is because octogenarian women are well past menopause, the impact of variation in age is minimal and octogenarians represent a selected population of survivors. Based on previous studies of nonoctogenarians, it is generally accepted that the apo €4 allele is associated with increased, and the apo €2 allele with decreased, risk of CAD [Cumming and Robertson, 1984; Davignon et al., 198813; Kuusi et al., 1989; Hixson et al., 1991; Pedro-Botet et al., 1992; Eichner et al., 1993; StengArd et al., 19951 . Therefore, it is expected that the relative frequency of apo €4 will be decreased and apo €2 increased in individuals who reach their eightieth decade as compared to subjects of a younger age group. This hypothesis is supported by the relative frequencies observed in this sample [Davignon et al., 1988a, 19891 and others [Cauley et al., 1993; Eggertsen et al., 1993; Kervinen et al., 1994; Louhija et al., 1994; Schachter et al., 19941. In this sample of octogenarians, the males were healthier than the females with regard to plasma lipid levels and presence of disease. The plasma lipid means and variances were within the range reported in other studies of the elderly and as such this sample of octogenarians appears to be representative of octogenarians in general [Nicholson et al., 1979; Alvarez et al., 1984; Luc et al., 1991; Tietz et al., 19921 . The mean levels of the plasma lipids in this sample of octogenarian males were, in general, only slightly higher than those observed in males from a sample of younger Canadian individuals (mean age of 39 in males and 37 in females) [Xhignesse et al., 19911 . In contrast, the octogenarian females had much higher lipid levels than those observed in younger females. This result was not unexpected because previous studies have documented that average plasma lipid levels increase with age in both genders, that females have higher average levels than males in the elderly [Kritchevsky, 1978; Connor et al., 1982; Abbott et al., 1983; Kottke et al., 19911 , and that average total cholesterol, LDL-C and triglyceride levels begin to decrease in the last decades of life [Castelli et al., 1977; Dedonder-Decoopman et al., 1980; Herschcopf et al., 1982 ; National Center for Health Statistics et al., 19861. The cross-over of the male and female levels while aging [Williams et al., 19931 may be due to a steeper rise in plasma lipid levels in females than in males or due to the death of those males with high plasma lipid levels [Lamon-Fava et al., 19941 . The latter hypothesis is supported by the differences in relative apo E allele frequencies in samples of young and elderly individuals. Thus, it appears that the male and female octogenarians in this sample are at very different stages in the aging process with respect to lipid metabolism and also have differential selective mortality, even though they are chronologically the same age.
The contribution of variation in indices of aging and lifestyle, i.e., concomitants, to interindividual plasma lipid variability is gender-, age-and trait-dependent. As reported here, the relationships between plasma lipid traits and measures of aging and lifestyle, i.e., concomitants, differed among traits and between male and female octogenarians. So, as pointed out by others, the study of the causes of interindividual differences in levels of plasma lipid traits must be carried out separately in males and females [Reilly et al., 1990 [Reilly et al., , 1991 [Reilly et al., , 1992 Kaprio et al., 1991; Xhignesse et al., 1991; Kessling et al., 19921 . Also, the concomitants explained more of the interindividual trait variability (estimated as the percent sum of squares) in this sample of octogenarians than in a sample of healthy younger individuals, in which the same adjustment was used [Xhignesse et al., 19911 , in all traits except total cholesterol in males and LDL-C in females. This result could be due to the octogenarians having increased sum of squares attributable to the concomitants, especially glucose and uric acid levels, and/or decreased total sum of squares. The standard deviations of all the plasma lipid traits were greater in the octogenarians than in the sample of younger individuals [Xhignesse et al., 19911 . Thus, it may be inferred that the greater interindividual variability in plasma lipid levels in octogenarians reflects their exposure to a larger range of environmental factors, indexed by the concomitants measured here, andlor their longer exposure to the influence of a particular environmental factor. It also makes clear that inferences drawn from studies of younger individuals about the contribution of concomitant variability to plasma lipid trait variability are not applicable to older individuals.
The impact of apo E genotype variation on measures of LDL metabolism in this sample of male octogenarians confirms what has been observed by others in et al., 19911. These contradictory results may reflect a developmental change in the action of the apo E gene product. Heterogeneity of variance among genotype classes is thought to be due, in part, to gene by environment interaction [Reilly et al., 1991; Zerba and Sing, 19931 . Children have experienced relatively short times of exposure to different environments, implying that the smaller impact of apo E on variances could not be detected [de Knijff et al., 19931 . In contrast, an impact of apo E on variances would be detected in adults because of their exposure to a larger range of environmental factors andlor their longer exposure to a particular environmental factor. Finally, in octogenarians, the marginal, average effects of a single gene are likely to be small relative to the total accumulation of a lifetime of effects of interactions between a large range of environmental exposures and genetic variation [Zerba and Sing, 19931 . This is supported by the result that in both male and female octogenarians in this sample, more than 50% of the interindividual variability for all plasma lipid traits was not explained by the predictors considered here.
The apo E gene acts not only as a level and variability gene, but also as a covariability gene [Reilly et al., 19941 . In other words, variation in the apo E gene associates with differences in the relationships between the agents involved in lipid metabolism. Because the previous studies [Boenvinkle et al., 1987; Reilly et al., 19941 that estimated the effect of apo E on correlations used different plasma lipid traits, adjusted for concomitants in a different way, had different relative apo E allele frequencies and, in one study [Boerwinkle et al., 19871 , combined males and females, it is inappropriate to make comparisons of specific correlations with the estimates reported here.
Despite the above caveats, certain general conclusions can be made. First, the strong invariant forces between adjusted plasma lipid traits identified in this sample of octogenarians, LDL-C : LDL-B, triglycerides: VLDL-C, triglycerides : VLDL-B and VLDL-C :VLDL-B, have been observed by others in samples of younger individuals [Reilly et al., 1994; Roy et al., 19951 . This suggests that the strong forces among agents involved in lipid metabolism measure characteristics common to all age, gender and genotype groups. These correlations may reflect the long evolutionary history of the lipid metabolism system [Weiss, 19931. In contrast, those correlations that were heterogeneous among genotype groups reflect the effects of short term evolutionary events, such as the creation of the apo E polymorphism. Correlations between plasma lipid traits have been found to be heterogeneous among the common apo E genotypes in all other studies that addressed this question [Boenvinkle et al., 1987; Despres et al., 1993; Reilly et al., 19941 , supporting the generality of the inferences reported here.
Finally, the differences in correlations between the genders and between samples of younger and older individuals may reflect the epigenetic effects of the gender-specific physiological changes of aging. In the one other study in which males and females were considered separately, gender influenced the manner in which younger samples [Sing and Davignon, 1985; Boenvinkle et al., 1987; Davignon et al., 1988b; Kaprio et al., 1991; Reilly et al., 1991; Xhignesse et al., 1991; Davignon, 19931 . But it should be noted that the association in octogenarian males was primarily due to the lower mean levels of these traits in ~312s; ~413s had adjusted total cholesterol, LDL-C, apo B and LDL-B levels very close to and even below those seen in ~313s. Thus, it can be hypothesized that the decrease in the frequency of the apo €4 allele observed in the males may be due to those males with the apo €413 (and perhaps apo &4) genotype and the highest levels of plasma LDL-C and apo B levels not being sampled, either because of the sample selection criteria or death from CAD or other chronic diseases such as Alzheimer's disease [Poirier et al., 1993; Strittmatter et al., 19931 . In contrast to the males, variation in the apo E gene did not have a statistically significant impact on adjusted plasma lipid levels in this sample of female octogenarians. Thus, even though it has been hypothesized by others that the impact of apo E genotype variation is homogeneous across populations [Hallman et al., 19911 , the results reported here suggest instead that apo E allele frequencies and effects are context-dependent within this particular subdivision of the Canadian population. This result is supported by a study of individuals aged 5-90 which found that the variance in measures of lipid metabolism associated with the apo E genotypes is dependent on gender and age (Zerba, personal communication, 1995) .
Results of studies in younger individuals have been inconsistent with regard to whether individuals with the €312 genotype, in general, have higher or lower triglyceride levels compared with individuals with either the €313 or €413 genotypes (reviewed by Davignon, 1993) . Davignon hypothesized that the inconsistent results may be due to a difference in the impact of the apo E polymorphism in "healthy" versus "unhealthy" individuals; that is, the €2 allele may be associated with lower triglyceride levels in "healthy" individuals and with higher triglyceride levels in others [Davignon, 19931. This hypothesis is supported by this study; the €312 genotype was associated with lower triglyceride levels in males (who in general were free from CAD risk factors) and with higher triglyceride levels in females (who appeared to be less healthy than the males) as compared to the €313 or €413 genotypes. These results should be taken as preliminary because the triglyceride differences between the apo E genotypes within each gender were not statistically significant. Even so, these results further support the hypothesis that the impact of variation in the apo E gene is context-dependent.
Variation in the apo E gene appeared to have little or no effect on intragenotypic trait variance in this sample of octogenarians. This result is supported by a study of teenage twins in which the null hypothesis that apo E does not act as a variability gene [Berg, 19901 was not rejected [de Knijff et al., 19933 . In contrast, the intragenotypic variances of many traits including total cholesterol, triglycerides, apo B, apo AII, apo E and apo CIII were found to be heterogeneous among apo E genotypes in a sample of adults [Kaprio et al., 1991 ; Reilly the correlations differed among the apo E genotypes, suggesting this result is not peculiar to our study of octogenarians [Reilly et al., 19941 . Although we cannot compare specific correlations among the different studies because of the reasons mentioned above, it is clear that the strength of some relationships among plasma lipid levels are age-dependent. This is supported by Reilly et al. 119901 who demonstrated heterogeneity of the variance-covariance matrices of pairs of plasma lipid and lipoprotein traits among three generations (children, parents and grandparents). In summary, the observed correlations reflect the effects of changes in culture and the genome over three time scales: long evolutionary history, short evolutionary history and lifecycle history.
CONCLUSIONS
The results from this study of octogenarians suggest that aging can be thought of in two ways: as an index for selection and for physiological change. We hypothesize that octogenarian males represent a sample of individuals in which selective mortality has occurred. This follows from the observation that most of the plasma lipid traits were less variable in the octogenarian males than in the females. Also, the average lipid levels in these males resemble those measured in samples of younger adult males and the impact of variation in the apo E gene on mean plasma lipid levels is, in general, the same. But octogenarian males with the ~4 / 3 genotype did not have higher LDL-C or apo B levels than ~3 / 3 or ~3 / 2 males. The relative frequency of the €4 allele was also found to be reduced in this sample, suggesting that those ~4 / 3 individuals with high lipid levels were not sampled, either because of the sample selection criteria or because they were selectively removed from the population by early death from CAD or other chronic diseases such as Alzheimer's disease. In support of this selective mortality hypothesis, a longitudinal study of Finnish men demonstrated that the €4 allele was associated with increased CAD mortality [Stengbrd et al., 19951 . Variation in only a few genes has previously been associated with survival in humans [Proust et al., 1982; Takata et al., 1987; Kramer et al., 1991; Lagaay et al., 19911 ; apo E joins the list as an example of a gene involved in influencing variation in the aging process [Kervinen et al., 1994; Schachter et al., 19941. Female octogenarians in this sample had a much more severe CAD risk profile than males and thus male and female octogenarians may be at different physiological ages. We hypothesize that female octogenarians, as a group, are just entering a period of increased mortality from CAD and other chronic diseases. This would explain the higher incidence of CAD, hypertension and hypothyroidism in the females and their severe CAD risk profile. Thus, the results from this study suggest that age is an index for the rate of selective mortality due to CAD and other chronic diseases but that the rates are different in female and male octogenarians.
Aging is also an index of physiological change, and the male and female octogenarians are at different physiological stages not only with respect to lipid metabolism in general, but also with respect to the impact of variation in the apo E gene on lipid metabolism.
The plasma lipid trait means and variances were higher in this sample of female octogenarians than what has been observed in samples of younger individuals. Also, the concomitants explained more of the interindividual plasma lipid trait variability in this sample of octogenarians than what has been found in other samples. Thus, the means and variances of plasma lipid levels as well as the contribution of environmental factors to interindividual variability in plasma lipid levels change as a function of aging.
Our study contributes to the growing body of evidence that, in addition to having an impact on average trait levels, common allelic variations in the apo E gene associate with differences in the pattern of relationships between intermediate biological traits in the network of agents that link genome type variation with variation in risk of disease. Further, this study documents that the genetic architecture of a quantitative CAD risk factor trait cannot be a static characterization. Instead it must be a dynamic summarization that is dependent on the context defined by exposures to environments during the lifecycle that are indexed by gender, age, and the population of inference. Partial: the percent sum of squares for the concomitant; total: the percent sum of squares for the model. bThe concomitants are listed in the order in which they were added to the model; thus, the sum of squares is conditional on the concomitants already entered into the regression model.
' Statistically significant, P-value 5 0.05.
moved (data log,-transformed and untransformed).
without outliers). "The correlation was categorized in the next higher level in the figures (e.g., no line to thin line) when the trait(s) was log,-transformed before the adjustment. The correlation was categorized in the next lower level in the figures (e.g., thin line to no line) when the trait(s) was log,-transformed before the adjustment.
* If the inferences about a correlation changed when the trait(s1 was log,-transformed before the adjustment, the P-value for the correlation after transformation is given in parentheses. "The correlation difference was categorized in the next higher level in the figures (e.g., no line to thin line) when the trait(s) was log,-transp m e d before the adjustment. The correlation difference was categorized in the next lower level in the figures (e.g., thin line to no line) when the traitb) was log,-transformed before the adjustment.
* If the inferences about a correlation difference changed when the trait(s) was log.-transformed before the adjustment, the P-value for the correlation difference after transformation is given in parentheses.
